Performance of compulsive behavior in rats is not a unitary phenomenon - validation of separate functional components in compulsive checking behavior

European Journal of Neuroscience

Volumn 40, Issue 6, 2014, Pages 2971-2979

  Tucci, Mark C ^a   Dvorkin Gheva, Anna ^a   Johnson, Eric ^a   Cheon, Paul ^a   Taji, Leena ^a   Agarwal, Arnav ^a   Foster, Jane ^a   Szechtman, Henry ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

8 hydroxy 2 (di n propylamino) tetralin hydrochloride; Analysis and synthesis; Animal model; Compulsive checking behavior; Nucleus accumbens core lesion

Indexed keywords

8 HYDROXY 2 (DI N PROPYLAMINO) TETRALIN HYDROCHLORIDE; QUINPIROLE; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; SEROTONIN 1 AGONIST;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPULSION; CONTROLLED STUDY; FRACTIONATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OBSESSIVE COMPULSIVE DISORDER; PHENOTYPE; PRIORITY JOURNAL; RAT; SATIETY; TASK PERFORMANCE; ANIMAL; DISEASE MODEL; DRUG EFFECTS; INJURIES; LONG EVANS RAT; METABOLISM; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; VALIDATION STUDY;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; COMPULSIVE BEHAVIOR; DISEASE MODELS, ANIMAL; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; OBSESSIVE-COMPULSIVE DISORDER; PHENOTYPE; RATS, LONG-EVANS; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN 5-HT1 RECEPTOR AGONISTS;

EID: 84927787166     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12652     Document Type: Article

References (75)

1. Ahlenius, S. & Larsson, K. (1997) Specific involvement of central 5-HT1A receptors in the mediation of male rat ejaculatory behavior. Neurochem. Res., 22, 1065-1070.
2. Albert, P.R. & Le François, B. (2010) Modifying 5-HT1A receptor gene expression as a new target for antidepressant therapy. Front. Neurosci., 4, 35.
3. Alkhatib, A.H., Dvorkin-Gheva, A. & Szechtman, H. (2013) Quinpirole and 8-OH-DPAT induce compulsive checking behavior in male rats by acting on different functional parts of an OCD neurocircuit. Behav. Pharmacol., 24, 65-73.
4. Aouizerate, B., Guehl, D., Cuny, E., Rougier, A., Bioulac, B., Tignol, J. & Burbaud, P. (2004) Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology. Prog. Neurobiol., 72, 195-221.
5. Aouizerate, B., Guehl, D., Cuny, E., Rougier, A., Burbaud, P., Tignol, J. & Bioulac, B. (2005) Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder. Neuropsychiatr. Dis. Treat., 1, 231-243.
6. Barnes, N.M. & Sharp, T. (1999) A review of central 5-HT receptors and their function. Neuropharmacology, 38, 1083-1152.
7. Barr, L.C., Goodman, W.K. & Price, L.H. (1993) The serotonin hypothesis of obsessive compulsive disorder. Int. Clin. Psychopharm., 8(Suppl 2), 79-82.
8. Ben Pazi, A., Szechtman, H. & Eilam, D. (2001) The morphogenesis of motor rituals in rats treated chronically with the dopamine agonist quinpirole. Behav. Neurosci., 115, 1301-1317.
9. Bloch, M.H., Landeros-Weisenberger, A., Kelmendi, B., Coric, V., Bracken, M.B. & Leckman, J.F. (2006) A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol. Psychiatr., 11, 622-632.
10. Carli, M., Baviera, M., Invernizzi, R.W. & Balducci, C. (2005) Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats. Neuropsychopharmacology, 31, 757-767.
11. Clément, P., Bernabé, J., Kia, H.K., Alexandre, L. & Giuliano, F. (2006) D2-like receptors mediate the expulsion phase of ejaculation elicited by 8-hydroxy-2-(di-N-propylamino)tetralin in rats. J. Pharmacol. Exp. Ther., 316, 830-834.
12. Dougherty, D.D., Rauch, S.L. & Jenike, M.A. (2004) Pharmacotherapy for obsessive-compulsive disorder. J. Clin. Psychol., 60, 1195-1202.
13. Drai, D. & Golani, I. (2001) SEE: a tool for the visualization and analysis of rodent exploratory behavior. Neurosci. Biobehav. R., 25, 409-426.
14. Drai, D., Benjamini, Y. & Golani, I. (2000) Statistical discrimination of natural modes of motion in rat exploratory behavior. J. Neurosci. Meth., 96, 119-131.
15. Dvorkin, A., Culver, K.E. & Szechtman, H. (2006a) Differential effects of clorgyline on sensitization to quinpirole in rats tested in small and large environments. Psychopharmacology, 186, 534-543.
16. Dvorkin, A., Perreault, M.L. & Szechtman, H. (2006b) Development and temporal organization of compulsive checking induced by repeated injections of the dopamine agonist quinpirole in an animal model of obsessive-compulsive disorder. Behav. Brain Res., 169, 303-311.
17. Dvorkin, A., Silva, C., McMurran, T., Bisnaire, L., Foster, J. & Szechtman, H. (2010) Features of compulsive checking behavior mediated by nucleus accumbens and orbital frontal cortex. Eur. J. Neurosci., 32, 1552-1563.
18. Eilam, D. & Golani, I. (1989) Home base behavior of rats (Rattus norvegicus) exploring a novel environment. Behav. Brain Res., 34, 199-211.
19. Eilam, D. & Szechtman, H. (2005) Psychostimulant-induced behavior as an animal model of obsessive-compulsive disorder: an ethologlocal approach to the form of compulsive rituals. CNS Spectr., 10, 191-202.
20. Eilam, D., Golani, I. & Szechtman, H. (1989) D2-agonist quinpirole induces perseveration of routes and hyperactivity but no perseveration of movements. Brain Res., 490, 255-267.
21. Filip, M. & Bader, M. (2009) Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system. Pharmacol. Rep., 61, 761-777.
22. Fink, K.B. & Göthert, M. (2007) 5-HT receptor regulation of neurotransmitter release. Pharmacol. Rev., 59, 360-417.
23. Glennon, J.C., Van Scharrenburg, G., Ronken, E., Hesselink, M.B., Reinders, J.-H., Van Der Neut, M., Long, S.K., Feenstra, R.W. & McCreary, A.C. (2006) In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist. Synapse, 60, 599-608.
24. Golani, I., Benjamini, Y. & Eilam, D. (1993) Stopping behavior: constraints on exploration in rats (Rattus norvegicus). Behav. Brain Res., 53, 21-33.
25. Goodman, W.K., McDougle, C.J., Price, L.H., Riddle, M.A., Pauls, D.L. & Leckman, J.F. (1990) Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? J. Clin. Psychiat., 51(Suppl), 36-43; discussion 55-58.
26. Graybiel, A.M. & Rauch, S.L. (2000) Toward a neurobiology of obsessive-compulsive disorder. Neuron, 28, 343-347.
27. Greist, J.H., Bandelow, B., Hollander, E., Marazziti, D., Montgomery, S.A., Nutt, D.J., Okasha, A., Swinson, R.P. & Zohar, J. (2003) WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. CNS Spectr., 8, 7-16.
28. Hayes, D.J. & Greenshaw, A.J. (2011) 5-HT receptors and reward-related behaviour: a review. Neurosci. Biobehav. R., 35, 1419-1449.
29. Hen, I., Sakov, A., Kafkafi, N., Golani, I. & Benjamini, Y. (2004) The dynamics of spatial behavior: how can robust smoothing techniques help? J. Neurosci. Meth., 133, 161-172.
30. Hinds, A.L., Woody, E.Z., Van Ameringen, M., Schmidt, L.A. & Szechtman, H. (2012) When too much is not enough: obsessive-compulsive disorder as a pathology of stopping, rather than starting. PLoS One, 7, e30586.
31. Hoyer, D., Hannon, J.P. & Martin, G.R. (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Be., 71, 533-554.
32. Huey, E.D., Zahn, R., Krueger, F., Moll, J., Kapogiannis, D., Wassermann, E.M. & Grafman, J. (2008) A psychological and neuroanatomical model of obsessive-compulsive disorder. J. Neuropsych. Clin. N., 20, 390-408.
33. Ichimaru, Y., Egawa, T. & Sawa, A. (1995) 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Jpn. J. Pharmacol., 68, 65-70.
34. Jongen-Relo, A.L. & Feldon, J. (2002) Specific neuronal protein: a new tool for histological evaluation of excitotoxic lesions. Physiol. Behav., 76, 449-456.
35. Koran, L.M. (2004) Augmentation strategies for treatment resistant obsessive-compulsive disorder. Clin. Neuropsychiatry, 1, 65-71.
36. van Kuyck, K., Demeulemeester, H., Feys, H., De Weerdt, W., Dewil, M., Tousseyn, T., De Sutter, P., Gybels, J., Bogaerts, K., Dom, R. & Nuttin, B. (2003) Effects of electrical stimulation or lesion in nucleus accumbens on the behaviour of rats in a T-maze after administration of 8-OH-DPAT or vehicle. Behav. Brain Res., 140, 165-173.
37. Leckman, J.F., Grice, D.E., Barr, L.C., de Vries, A.L., Martin, C., Cohen, D.J., McDougle, C.J., Goodman, W.K. & Rasmussen, S.A. (1994) Tic-related vs. non-tic-related obsessive compulsive disorder. Anxiety, 1, 208-215.
38. Leger, L., Charnay, Y., Hof, P.R., Bouras, C. & Cespuglio, R. (2001) Anatomical distribution of serotonin-containing neurons and axons in the central nervous system of the cat. J. Comp. Neurol., 433, 157-182.
39. Marazziti, D., Mungai, F., Vivarelli, L. & Dell'Osso, B. (2004) Critical issues in the pharmacological treatment of obsessive-compulsive disorder. Clin. Neuropsy. J. Treat. Eval., 1, 59-64.
40. Matuszewich, L., Lorrain, D.S., Trujillo, R., Dominguez, J., Putnam, S.K. & Hull, E.M. (1999) Partial antagonism of 8-OH-DPAT'S effects on male rat sexual behavior with a D2, but not a 5-HT1A, antagonist. Brain Res., 820, 55-62.
41. Navailles, S. & De Deurwaerdere, P. (2011) Presynaptic control of serotonin on striatal dopamine function. Psychopharmacology, 213, 213-242.
42. Newman-Tancredi, A., Cussac, D., Audinot, V. & Millan, M.J. (1999) Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors. N.-S. Arch. Pharmacol., 359, 447-453.
43. Nikolaus, S., Antke, C., Beu, M. & Muller, H.W. (2010) Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders - results from in vivo imaging studies. Rev. Neuroscience, 21, 119-139.
44. Njung'e, K. & Handley, S.L. (1991) Evaluation of marble-burying behavior as a model of anxiety. Pharmacol. Biochem. Be., 38, 63-67.
45. Noldus, L.P., Spink, A.J. & Tegelenbosch, R.A. (2001) EthoVision: a versatile video tracking system for automation of behavioral experiments. Behav. Res. Meth. Ins. C., 33, 398-414.
46. Paxinos, G. & Watson, C. (1998) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego, CA.
47. Pitman, R.K. (1989) Animal models of compulsive behavior. Biol. Psychiat., 26, 189-198.
48. Rasmussen, S.A. & Eisen, J.L. (1992) The epidemiology and differential-diagnosis of obsessive-compulsive disorder. J. Clin. Psychiat., 53, 4-10.
49. Rinken, A., Ferré, S., Terasmaa, A., Owman, C. & Fuxe, K. (1999) Serotonergic agonists behave as partial agonists at the dopamine D2 receptor. NeuroReport, 10, 493-495.
50. Saxena, S., Brody, A.L., Schwartz, J.M. & Baxter, L.R. (1998) Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Brit. J. Psychiat. Suppl., 35, 26-37.
51. Shin, E., Garcia, J., Winkler, C., Björklund, A. & Carta, M. (2012) Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease. Neurobiol. Dis., 47, 393-406.
52. Smith, C.F. & Cutts, S. (1990) Dopamine agonist activity of 8-OH-DPAT. Arch. Int. Pharmacod. T., 306, 106-113.
53. Spink, A.J., Tegelenbosch, R.A., Buma, M.O. & Noldus, L.P. (2001) The EthoVision video tracking system - a tool for behavioral phenotyping of transgenic mice. Physiol. Behav., 73, 731-744.
54. Stein, D.J. (2002) Obsessive-compulsive disorder. Lancet, 360, 397-405.
55. Summerfeldt, L.J. (2004) Understanding and treating incompleteness in obsessive-compulsive disorder. J. Clin. Psychol., 60, 1155-1168.
56. Szechtman, H. & Eilam, D. (2005) Psychiatric models. In Whishaw, I.Q. & Kolb, B. (Eds), The Behavior of the Laboratory Rat: A Handbook with Tests. Oxford University Press, New York, pp. 462-474.
57. Szechtman, H. & Woody, E. (2004) Obsessive-compulsive disorder as a disturbance of security motivation. Psychol. Rev., 111, 111-127.
58. Szechtman, H., Talangbayan, H., Canaran, G., Dai, H. & Eilam, D. (1994) Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism [published erratum appears in Psychopharmacology (Berl.) 1994 Sep; 116(1), 124]. Psychopharmacology, 115, 95-104.
59. Szechtman, H., Sulis, W. & Eilam, D. (1998) Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD). Behav. Neurosci., 112, 1475-1485.
60. Szechtman, H., Culver, K. & Eilam, D. (1999) Role of dopamine systems in obsessive-compulsive disorder (OCD): implications from a novel psychostimulant-induced animal model. Pol. J. Pharmacol., 51, 55-61.
61. Szechtman, H., Shivji, S. & Woody, E.Z. (2014) Pathophysiology of obsessive-compulsive disorder: insights from normal function and neurotoxic effects of drugs, infection and brain injury. In Kostrzewa, R.M. (Ed.), Handbook of Neurotoxicity. Springer, London, pp. 2231-2253.
62. Teitelbaum, P. (2012) Some useful insights for graduate students beginning their research in physiological psychology: anecdotes and attitudes. Behav. Brain Res., 231, 234-249.
63. Teitelbaum, P. & Pellis, S.M. (1992) Toward a synthetic physiological psychology. Psychol. Sci., 3, 4-20.
64. Tolkamp, B.J. & Kyriazakis, I. (1999) To split behaviour into bouts, log-transform the intervals. Anim. Behav., 57, 807-817.
65. Tolkamp, B.J., Allcroft, D.J., Austin, E.J., Nielsen, B.L. & Kyriazakis, I. (1998) Satiety splits feeding behaviour into bouts. J. Theor. Biol., 194, 235-250.
66. Tucci, M.C., Dvorkin-Gheva, A., Graham, D., Amodeo, S., Cheon, P., Kirk, A., Peel, J., Taji, L. & Szechtman, H. (2013) Effects of the serotonergic agonist mCPP on male rats in the quinpirole sensitization model of obsessive-compulsive disorder (OCD). Psychopharmacology, 227, 277-285.
67. Tucci, M.C., Dvorkin-Gheva, A., Sharma, R., Taji, L., Cheon, P., Peel, J., Kirk, A. & Szechtman, H. (2014) Separate mechanisms for development and performance of compulsive checking in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD). Psychopharmacology, doi: 10.1007/s00213-014-3505-6. [Epub ahead of print].
68. Wahl, K., Salkovskis, P.M. & Cotter, I. (2008) 'I wash until it feels right' - the phenomenology of stopping criteria in obsessive-compulsive washing. J. Anxiety Disord., 22, 143-161.
69. Westenberg, H.G., Fineberg, N.A. & Denys, D. (2007) Neurobiology of obsessive-compulsive disorder: serotonin and beyond. CNS Spectr., 12, 14-27.
70. van Wijngaarden, I., Tulp, M.T. & Soudijn, W. (1990) The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol., 188, 301-312.
71. Winstanley, C.A., Chudasama, Y., Dalley, J.W., Theobald, D.E., Glennon, J.C. & Robbins, T.W. (2003) Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats. Psychopharmacology, 167, 304-314.
72. Wise, S. & Rapoport, J.L. (1989) Obsessive compulsive disorder - is it a basal ganglia dysfunction? In Rapoport, J. (Ed.), Obsessive Compulsive Disorder in Children and Adolescence. American Psychiatric Press, Washington, DC, pp. 327-344.
73. Yadin, E., Friedman, E. & Bridger, W.H. (1991) Spontaneous alternation behavior: an animal model for obsessive-compulsive disorder? Pharmacol. Biochem. Be., 40, 311-315.
74. Zohar, J., Chopra, M., Sasson, Y., Amiaz, R. & Amital, D. (2000) Obsessive compulsive disorder: serotonin and beyond. World J. Biol. Psychia., 1, 92-100.
75. Zor, R., Szechtman, H., Hermesh, H., Fineberg, N.A. & Eilam, D. (2011) Manifestation of incompleteness in obsessive-compulsive disorder (OCD) as reduced functionality and extended activity beyond task completion. PLoS One, 6, e25217.